Indoco Remedies Ltd. Announces 78th AGM, Reports 10.3% Growth in Domestic Formulation Business

Indoco Remedies Ltd. has announced its 78th Annual General Meeting (AGM) and released its Annual Report for the financial year 2024-25. The company reported a 10.3% growth in its domestic formulation business, which stood at ₹ 934 crores. The international formulation business was ₹ 501 crores, and the API business was ₹ 130 crores. The company's Earnings Before Interest, Taxes, Depreciation, and Amortization (EBIDTA) to net sales stood at 6% at ₹ 99.25 crores. The AGM is scheduled for 10:30 a.m., IST, Thursday, 11th September, 2025. Indoco Remedies Ltd. continues to ensure access to quality and affordable healthcare in India and across the globe, with a focus on reducing manufacturing costs and maintaining supply of quality products consistently.